Company: SCLXW
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0000950170-25-071920
Chunk: 85

Company: Scilex Holding Co
Filing Date: 2025-05-15
Form: 424B3
Chunk 85
---
 (whether under the Oramed Note, the Tranche B Notes or otherwise) for at least the next 12 months. If these sources are insufficient to satisfy our liquidity requirements, we may seek to raise additional funds through equity offerings, debt financings, collaborations, government contracts or other strategic transactions.

<div align='center'>49</div>

Cash Flows The following table summarizes our cash flows for each of the periods presented (in thousands):

| Cash Flow Data:                                          |     | Three Months Ended March 31, 
 2025                         |        |   |     | 2024 |         |   |
|:---------------------------------------------------------|:----|:-----------------------------|-------:|:--|:----|:-----|--------:|:--|
| Net cash proceeds from operating activities              |     | $                            |  6,007 |   |     | $    |   9,391 |   |
| Net cash used for investing activities                   |     |                              |   (395 | ) |     |      |    (150 | ) |
| Net cash used for financing activities                   |     |                              | (3,084 | ) |     |      | (11,196 | ) |
| Net change in cash, cash equivalents and restricted cash |     | $                            |  2,528 |   |     | $    |  (1,955 | ) |

Cash Flows from Operating Activities For the three months ended March 31, 2025, net cash proceeds from operating activities were approximately $6.0 million, attributable to the changes in operating assets and liabilities that provided $27.2 million of cash and other non-cash reconciling items of $4.9 million related to stock-based compensation, change in fair value of debt and liability instruments, financing costs, depreciation and amortization and non-cash operating lease cost and change on fair value of derivative liabilities, partially offset by our net loss of $26.1 million. For the three months ended March 31, 2024, net cash proceeds from operating activities were approximately $9.3 million, attributable to the changes in operating assets and liabilities that provided $23.1 million of cash and other non-cash reconciling items of $10.6 million related to loss on derivative liabilities, stock-based compensation, change in fair value of debt and liability instruments, depreciation and amortization and non-cash operating lease cost, partially offset by our net loss of $24.4 million. Cash